Company Filing History:
Years Active: 2012-2013
Title: Charon Ganellin: Innovator in Pharmaceutical Chemistry
Introduction
Charon Ganellin is a notable inventor based in Thame, GB, recognized for her contributions to pharmaceutical chemistry. She has been instrumental in developing innovative treatments for various medical conditions, particularly in the field of sleep apnea.
Latest Patents
Ganellin holds two patents, with her latest inventions focusing on the monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine. This invention provides a method for treating sleep apnea and other related conditions. The crystalline compound is characterized by an X-ray diffractogram that includes specific peaks, indicating its unique properties and effectiveness.
Career Highlights
Throughout her career, Charon Ganellin has made significant strides in the pharmaceutical industry. Her work has led to advancements in drug formulations and therapeutic applications, showcasing her expertise and dedication to improving patient outcomes.
Collaborations
Ganellin has collaborated with esteemed colleagues, including Manuel M Raga and Juan Sallares, to further her research and development efforts. These partnerships have enhanced the scope and impact of her work in the field.
Conclusion
Charon Ganellin's innovative contributions to pharmaceutical chemistry, particularly in the treatment of sleep apnea, highlight her role as a leading inventor. Her patents and collaborations reflect her commitment to advancing medical science and improving health outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.